This increase is similar in magnitude to BRCA1 and BRCA2 gene variants and breast cancer risk, which are far less common (prevalence of 0.2–0.3%) and trigger more frequent cancer screening.18 This evidence concerns the gene BRCA2 and breast carcinoma.